ALISERTIB |
ALISERTIB : Inhibitor of AURKA
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| AURKA |
|
|
Inhibitor
up to 100 nM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
Alisertib has less activity against AURKB, with an IC50 value of 396.5 nM and showed selectivity in ...
In Cell Selectivity Assessment
Potency Assay Off-Target:
In HeLa cells, Alisertib is very selective against AURKB (IC50 = 1,534 nM)
Potency Cellular
In Vitro
AURKA
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/cb100053q
In Vivo Validations
Mouse
Dose: 5, 10, 30 mg/Kg
Route of delivery:
Oral
Target engagement assay:
Alisertib treatment resulted in a dose-dependent TGI of 43.3%, 84.2%, and 94.7% for the 3, 10, and 30 mg/kg groups, respectively
DOI Reference: 10.1158/1078-0432.CCR-11-1536
Chemical Information
| Molecular Formula | C27H20ClFN4O4 |
| SMILEs | COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O |
| InChI | InChI=1S/C27H20ClFN4O4/c1-36-21-5-3-4-20(29)23(21)25-19-10-15(28)6-8-17(19)24-14(12-30-25)13-31-27(33-24)32-16-7-9-18(26(34)35)22(11-16)37-2/h3-11,13H,12H2,1-2H3,(H,34,35)(H,31,32,33) |
| Molecular weight | 518.12 Da |
| AlogP | 5.7461 |
| HBond acceptors | 8 |
| HBond donors | 2 |
| Atoms | 57 |
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.